Loading clinical trials...

Preliminary Outcomes of Sacral Neuromodulation Applications; Tertiary-Center Experience in Turkey | Clinical Trials | Clareo Health

COMPLETED

Preliminary Outcomes of Sacral Neuromodulation Applications; Tertiary-Center Experience in Turkey

NCT06098963•Cigli Regional Training Hospital

View on ClinicalTrials.gov

Summary

to report our patients' outcomes of SNM in tertiary health centres in Turkey

Detailed Description

We retrospectively analyzed 18 patients who underwent SNM for urinary or bowel dysfunction between 2017 and 2022 in our clinic. We excluded 2 patients due to non-effective responses after the test period. After local ethics committee approval was obtained from our institute (Number and date: 21-12.1T/14). Patient characteristics and demographic data including age, gender, indications to the SNM, age at diagnosis, and comorbidities were collected from our Hospital patients' record system. Urinary functions were evaluated by the ICIQ-SF questionnaire form. Patients' diagnosis, implantation duration, complications, and improvement of symptoms were recorded.

Eligibility

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients diagnosed with urinary incontinence
•Patients diagnosed with faecal incontinence
•Patients diagnosed with interstitial cystitis

Exclusion Criteria

•Presence of urinary infection
•Presence of previous incontinence surgery
•Presence of 2nd motor neurone disease
•Inability of detrusor muscle contraction activity
•Previous radical cystoprostatectomy history
•Presence of bladder outlet obstruction

Key Dates

Start Date

January 1, 2017

Primary Completion Date

January 1, 2022

Completion Date

January 1, 2023

Last Updated

October 25, 2023

Enrollment

ACTUAL participants

Conditions

Sacral Neuromodulation

Interventions

sacral neuromodulation

DEVICE

Cost Profile and Budget Implications of Rechargeable Versus Non-rechargeable Sacral Neuromodulation Devices for Neurogenic Lower Urinary Tract Dysfunction

NCT07173517

Rechargeable Sacral Neuromodulation DeviceNeurogenic Lower Urinary Tract Dysfunction

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 25, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions